Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
about
Knowledge translation of research findingsImproving Decision Making about Genetic Testing in the Clinic: An Overview of Effective Knowledge Translation InterventionsThe impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysisRisk prediction tools for cancer in primary careImplementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issuesThe Human Genome Project, and recent advances in personalized genomicsWe screen newborns, don't we?: realizing the promise of public health genomicsGenetic risk prediction in complex diseaseAccuracy of recall of information about a cancer-predisposing BRCA1/2 gene mutation among patients and relatives.Effectiveness of a self-management intervention with personalised genetic and lifestyle-related risk information on coronary heart disease and diabetes-related risk in type 2 diabetes (CoRDia): study protocol for a randomised controlled trialDesign and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC StudyReflections on the cost of "low-cost" whole genome sequencing: framing the health policy debateEffect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trialThe effect of communicating the genetic risk of cardiometabolic disorders on motivation and actual engagement in preventative lifestyle modification and clinical outcome: a systematic review and meta-analysis of randomised controlled trials.Systems medicine and integrated care to combat chronic noncommunicable diseases.Lay perceptions of predictive testing for diabetes based on DNA test results versus family history assessment: a focus group studyInformation and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviourPublic preferences for communicating personal genomic risk information: a focus group studyPatient accounts of diagnostic testing for familial hypercholesterolaemia: comparing responses to genetic and non-genetic testing methods.Contemplating genetic feedback regarding lung cancer susceptibility.Effects of undergoing multiplex genetic susceptibility testing on parent attitudes towards testing their children.Diet and exercise changes following direct-to-consumer personal genomic testing.A preliminary exploration of college smokers' reactions to nicotine dependence genetic susceptibility feedback.Implementation and utilization of genetic testing in personalized medicine.Social and behavioral research in genomic sequencing: approaches from the Clinical Sequencing Exploratory Research Consortium Outcomes and Measures Working Group.Effect of communicating genetic and phenotypic risk for type 2 diabetes in combination with lifestyle advice on objectively measured physical activity: protocol of a randomised controlled trialUnaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing.Beyond public health genomics: proposals from an international working group.Disclosure of genetic information and change in dietary intake: a randomized controlled trial.Smokers' beliefs about the tobacco control potential of "a gene for smoking": a focus group study.Design and baseline characteristics of the Food4Me study: a web-based randomised controlled trial of personalised nutrition in seven European countriesGenome Medicine: past, present and future.'Genomic counseling'? Genetic counseling in the genomic era.'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq ProjectAssociations between self-referral and health behavior responses to genetic risk information."I don't mind damaging my own body" a qualitative study of the factors that motivate smokers to quitReturn of individual genetic results in a high-risk sample: enthusiasm and positive behavioral change.Young smokers' views of genetic susceptibility testing for lung cancer risk: minding unintended consequencesGenetic susceptibility testing and readiness to control weight: Results from a randomized controlled trial.Direct-to-consumer personalized genomic testing.
P2860
Q24288915-2D6C9DB9-B8E3-452C-80F1-76D4AE318671Q26764748-F7855894-82FB-4177-B811-C1E13BE23627Q26765401-5B340807-035B-422A-8343-B36F59AD3700Q26774974-1FAC6137-8330-4CB5-BDAF-505951736ACBQ26825771-019E9334-B0C9-48CC-A823-BEFB38FFEFF1Q26861372-AF7AB611-DA5D-42D9-A92F-5F16EAEC89CAQ27007571-932D9869-4B71-4061-8762-261F64939566Q27027720-26A521BC-8F26-42CC-8A48-BB07B7A0EBE1Q27324685-FB9288F6-E5F3-44BB-8107-555C1FD84ACAQ27335181-5E51E0C6-58A6-4103-B411-E59770B0FE79Q28652626-DBF44AA8-C4A0-43DB-B426-176D4B2EBF6EQ28661760-01DFD12C-E9F1-496C-8B51-9333C3EAC671Q28730647-D560B056-E851-4E3B-9051-F1890AC0DF81Q30249029-73BB9BED-5FF7-4C2B-9C14-ABE62886C760Q30395763-F03131BE-8FC4-469D-9846-0D7EF7C345D0Q30503462-C0B0776B-E095-4337-89D0-390848F49248Q30663945-2FCE166A-169B-415F-8C05-258B7B9A31EEQ30830961-6A901EA5-4586-41FB-B124-0F7DFA0012BBQ31096111-7C2B7726-9ECA-49A3-962B-AC598C80906EQ33560734-DFA380BB-2BB6-4CB9-99E1-94B2344ED2EFQ33560771-5D2CF67C-B68C-4F10-BCBF-A44A825522A0Q33623616-0692BDA4-0C5E-402A-B680-C393127877A9Q33821714-0F5AB12E-56B3-47BD-ABB5-EA7FAB031948Q34147916-C9E13208-092B-4B38-8222-1380F3E7E25EQ34175545-745FB6AA-B16E-4100-A830-DAD7EF8EDA78Q34307658-AD4271D6-DCB8-4461-9D1C-11B77EEBD355Q34401911-832D577D-F7FD-4C80-884D-AA6650CF3920Q34435782-AB2CA1D2-7E07-4717-ABA5-F73763D14159Q34513835-9AFB8744-5D2F-4853-A998-CE89CE10C876Q34649507-7E977579-950F-4D05-8D28-3A69896AA225Q34664117-3E5E3774-92A9-430E-9C99-8D0B6C5629A5Q34971361-E2280178-AB30-48F6-BC50-29E3CB441A1FQ34971372-51E7405C-A44D-4224-9276-41A2DEFAFD9DQ35012563-56DD6C02-B2C7-4A2A-9786-18A4C1B5FB14Q35030090-1256951E-CF02-4FEC-B5C4-86CD42613330Q35072731-765F01B7-EDF1-410A-8D3D-B976C8E7970AQ35132632-6600A164-DF55-4454-BA1B-7DEFE639A027Q35171778-5A8B2645-E044-476D-A773-82A5B8E9E54FQ35180643-F5233C65-59B4-4539-852B-15944986B2DCQ35230171-7E70B5B9-BBB7-4923-B155-7D0E0F402126
P2860
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
@ast
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
@en
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
@en-gb
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
@nl
type
label
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
@ast
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
@en
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
@en-gb
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
@nl
prefLabel
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
@ast
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
@en
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
@en-gb
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
@nl
P2093
P2860
P50
P1476
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
@en
P2093
Clare Watkinson
Gareth J Hollands
Simon J Griffin
Sophie Attwood
Theresa M Marteau
P2860
P304
P356
10.1002/14651858.CD007275.PUB2
P577
2010-10-06T00:00:00Z